Abstract
Adenosine deaminase (ADA), 5'nucleotidase (5'NT), ecto-5'NT, purine nucleoside phosphorylase (PNP), hypoxanthine-guanine phosphoribosyltransferase (HGPRT), adenine phosphoribosyltransferase (APRT), adenosine kinase (AK), AMP-deaminase (AMPD) and adenylate kinase (AdKin) activities were assayed in peripheral blood lymphoid cells from 20 patients with B-cell type chronic lymphocytic leukemia (CLL). Significantly decreased mean activities of ADA, 5'NT, ecto-5'NT, PNP and AMPD were observed when comparing B-CLL lymphoid cells with control peripheral blood lymphocytes (PBL). AK and AdKin activities however, were found to be higher in B-CLL. Relatively wide ranges of ADA and 5'NT activity were observed. In patients with paraproteinaemia, 5'NT activity was found to be relatively high and in the range of the activities in normal PBL. ADA activity seemed to be slightly higher in patients without paraproteinaemia. No correlation could be found between the enzyme activities and the number of cells rosetting with sheep erythrocytes or bearing surface immunoglobulin (sIg). A relationship was suggested between 5'NT activity and Ig production.
References
Aug 18, 1978·Science·N L EdwardsI H Fox
Nov 1, 1977·European Journal of Immunology·W E GathingsM D Cooper
Dec 1, 1976·British Journal of Haematology·A T HuangG L Engelbrecht
Mar 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·S GuptaF P Siegal
Mar 1, 1976·The Journal of Clinical Investigation·R TungR Hirschhorn
May 1, 1973·The Journal of Clinical Investigation·J LopesR Silber
Jan 1, 1980·Journal of Immunological Methods·J P Van LaarhovenC H De Bruyn
Jan 1, 1983·Leukemia Research·J P van LaarhovenE D Schretlen
Citations
Oct 30, 1987·Clinica Chimica Acta; International Journal of Clinical Chemistry·D M Goldberg, D Brown
Dec 1, 1986·Veterinary Immunology and Immunopathology·U M Sarmiento, V E Valli
Feb 1, 1991·Cancer Genetics and Cytogenetics·H XiaoA A Sandberg
Jan 1, 1995·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·A TabucchiR Pagani
Oct 20, 1993·Biochimica Et Biophysica Acta·A TabucchiR Pagani
Feb 1, 1991·Ophthalmology·H M KattanR K Forster
May 7, 1984·FEBS Letters·B I Srivastava, T Han
Mar 13, 2009·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·F CarlucciA Tabucchi
Jan 1, 1983·Leukemia Research·J P van Laarhoven, C H de Bruyn
May 24, 1997·Biochimica Et Biophysica Acta·F CarlucciA Tabucchi
Jan 1, 1987·Hematological Oncology·A D HoA V Hoffbrand
Mar 1, 1986·British Journal of Haematology·A D HoA V Hoffbrand
Jan 1, 1986·Leukemia Research·D De KorteA H van Gennip
Jun 1, 1988·Klinische Wochenschrift·A D Ho, K Ganeshaguru
Jun 18, 1993·Pharmacy World & Science : PWS·G H De BockJ D Mulder
Aug 15, 1987·International Journal of Cancer. Journal International Du Cancer·D de KorteA H van Gennip
Mar 1, 1988·American Journal of Hematology·J L Vives CorronsE Montserrat